CRISPR

CRISPR2-klf17

ID
ZDB-CRISPR-200323-2
Name
CRISPR2-klf17
Previous Names
None
Target
Sequence
5' - AGCACCGTGTATGACAGCGA - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
uy21 klf17
uy22 klf17
uy23 klf17
Expression
Gene expression in Wild Types + CRISPR2-klf17
No data available
Phenotype
Phenotype resulting from CRISPR2-klf17
No data available
Phenotype of all Fish created by or utilizing CRISPR2-klf17
Phenotype Fish Conditions Figures
posterior lateral line neuromast mislocalised posteriorly, abnormal klf17uy21/uy21 standard conditions Figure 2 with image from Suzuki et al., 2019
posterior lateral line neuromast decreased amount, abnormal klf17uy21/uy21 standard conditions Figure 2 with image from Suzuki et al., 2019
hatching gland he1.1 expression absent, abnormal klf17uy22/uy22 standard conditions Figure 7 with image from Suzuki et al., 2019
posterior lateral line neuromast mislocalised posteriorly, abnormal klf17uy22/uy22 standard conditions Figure 2 with image from Suzuki et al., 2019
posterior lateral line neuromast decreased amount, abnormal klf17uy22/uy22 standard conditions Figure 2 with image from Suzuki et al., 2019
posterior lateral line neuromast mislocalised posteriorly, abnormal klf17uy23/uy23 standard conditions Figure 2 with image from Suzuki et al., 2019
polster ctslb expression absent, abnormal klf17uy23/uy23 standard conditions Figure 6 with image from Suzuki et al., 2019
polster cd63 expression absent, abnormal klf17uy23/uy23 standard conditions Figure 6 with image from Suzuki et al., 2019
polster klf17 expression absent, abnormal klf17uy23/uy23 standard conditions Figure 6 with image from Suzuki et al., 2019
posterior lateral line neuromast decreased amount, abnormal klf17uy23/uy23 standard conditions Figure 2 with image from Suzuki et al., 2019
polster he1.1 expression absent, abnormal klf17uy23/uy23 standard conditions Figure 6 with image from Suzuki et al., 2019
hatching gland cell absent, abnormal klf17uy21/+; klf17uy22/+ standard conditions Figure 4 with image from Suzuki et al., 2019
hatching non-progressive, abnormal klf17uy21/+; klf17uy22/+ standard conditions Figure 3 with image from Suzuki et al., 2019
hatching gland ctslb expression absent, abnormal klf17uy21/+; klf17uy22/+ standard conditions Figure 5 with imageFigure 7 with image from Suzuki et al., 2019
hatching gland klf17 expression absent, abnormal klf17uy21/+; klf17uy22/+ standard conditions Figure 7 with image from Suzuki et al., 2019
whole organism viability, abnormal klf17uy21/+; klf17uy22/+ standard conditions Figure 3 with image from Suzuki et al., 2019
hatching gland cd63 expression absent, abnormal klf17uy21/+; klf17uy22/+ standard conditions Figure 7 with image from Suzuki et al., 2019
hatching gland cell absent, abnormal klf17uy22/+; klf17uy23/+ standard conditions Figure 4 with image from Suzuki et al., 2019
hatching gland ctslb expression absent, abnormal klf17uy22/+; klf17uy23/+ standard conditions Figure 5 with image from Suzuki et al., 2019
nucleate erythrocyte nucleus increased size, abnormal klf1uy19/uy19; klf17uy21/uy21 standard conditions Figure 3 with image from Suzuki et al., 2023
whole organism slc25a37 expression decreased amount, abnormal klf1uy19/uy19; klf17uy21/uy21 standard conditions Figure 6 with image from Suzuki et al., 2023
whole organism slc4a1a expression decreased amount, abnormal klf1uy19/uy19; klf17uy21/uy21 standard conditions Figure 6 with image from Suzuki et al., 2023
erythroblast decreased amount, abnormal klf1uy19/uy19; klf17uy21/uy21 standard conditions Figure 1 with image from Suzuki et al., 2023
intermediate cell mass of mesoderm slc4a1a expression decreased distribution, abnormal klf1uy19/uy19; klf17uy21/uy21 standard conditions Figure 5 with image from Suzuki et al., 2023
intermediate cell mass of mesoderm alas2 expression decreased distribution, abnormal klf1uy19/uy19; klf17uy21/uy21 standard conditions Figure 5 with image from Suzuki et al., 2023
whole organism alas2 expression decreased amount, abnormal klf1uy19/uy19; klf17uy21/uy21 standard conditions Figure 6 with image from Suzuki et al., 2023
intermediate cell mass of mesoderm slc25a37 expression decreased distribution, abnormal klf1uy19/uy19; klf17uy21/uy21 standard conditions Figure 5 with image from Suzuki et al., 2023
yolk erythroid progenitor cell decreased amount, abnormal klf1uy19/uy19; klf17uy21/uy21; ko05Tg standard conditions Figure 3 with image from Suzuki et al., 2023
Citations